Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
Status:
Completed
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, parallel-group, dose-ranging,
comparator-controlled study of the effect of pantoprazole on intragastric pH after successful
endoscopic hemostasis in hospitalized patients. Patients will receive either intravenous
pantoprazole (one of two regimens) or ranitidine (the comparator) within 2 hours of
successful hemostasis and administration will continue for 72 hours after hemostasis.